The nano-complexes showed more than three-fold and two-fold decreases in tumor volume and weight, respectively, compared to control and free siRNA, indicating successful targeted delivery of siRNA to the cancer site and suppression of BCL2. The gene discussed is BCL2; the disease is cancer.